Kite Pharma, Inc. (KITE)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
05-Oct-17 8:26 PM
View: 
Nussbaum Ran
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 9,832----(100%)
9.83K to 0
05-Oct-17 8:15 PM
View: 
Wiezorek Jeffrey
SVP Clinical Development
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 11,150----(43%)
25.82K to 14.67K
05-Oct-17 8:12 PM
View: 
Chang David D
EVP, R&D, Chief Medical Off.
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 16,605$180.00$2,988,900.00(100%)
16.61K to 0
05-Oct-17 8:24 PM
View: 
Humer Franz B
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 4,624$180.00$832,320.00(100%)
4.62K to 0
05-Oct-17 8:16 PM
View: 
Tomasello Shawn
Chief Commercial Officer
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 16,135$180.00$2,904,300.00(100%)
16.14K to 0
05-Oct-17 8:22 PM
View: 
Bonderman David
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 4,360----(< 1%)
2.41M to 2.41M
05-Oct-17 8:25 PM
View: 
Kazam Joshoa A
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 1,807----(41%)
4.36K to 2.55K
05-Oct-17 8:10 PM
View: 
Belldegrun Arie
Chairman, President and CEO
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 3,197,270$180.00$575,507,968.00(100%)
3.2M to 0
05-Oct-17 8:25 PM
View: 
Kazam Joshoa A
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 2,553$180.00$459,540.00(100%)
2.55K to 0
05-Oct-17 8:17 PM
View: 
Moore Timothy L.
EVP, Technical Operations
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 3,927$180.00$706,860.00(100%)
3.93K to 0
05-Oct-17 8:13 PM
View: 
Jenkinson Paul L
Chief Financial Officer
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 9,462----(76%)
12.46K to 3.0K
05-Oct-17 8:20 PM
View: 
Champsi Farah
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 61,467$180.00$11,064,100.00(100%)
61.47K to 0
05-Oct-17 8:15 PM
View: 
Wiezorek Jeffrey
SVP Clinical Development
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 14,674$180.00$2,641,320.00(100%)
14.67K to 0
05-Oct-17 8:14 PM
View: 
Kim Helen Susan
EVP, Business Development
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 4,193$180.00$754,740.00(100%)
4.19K to 0
05-Oct-17 8:27 PM
View: 
Clark Ian T
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 5,324----(75%)
7.1K to 1.78K
05-Oct-17 8:23 PM
View: 
Doumani Roy
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 150,620$180.00$27,111,600.00(86%)
175.69K to 25.07K
05-Oct-17 8:17 PM
View: 
Moore Timothy L.
EVP, Technical Operations
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 41,734----(91%)
45.66K to 3.93K
05-Oct-17 8:22 PM
View: 
Bonderman David
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 2,408,080----(100%)
2.41M to 0
05-Oct-17 8:14 PM
View: 
Kim Helen Susan
EVP, Business Development
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 17,500----(81%)
21.69K to 4.19K
05-Oct-17 8:19 PM
View: 
Witte Owen N.
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 58,535$180.00$10,536,300.00(100%)
58.53K to 0
05-Oct-17 8:26 PM
View: 
Nussbaum Ran
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 4,360----(31%)
14.19K to 9.83K
05-Oct-17 8:13 PM
View: 
Jenkinson Paul L
Chief Financial Officer
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 3,000$180.00$540,000.00(100%)
3.0K to 0
05-Oct-17 8:12 PM
View: 
Chang David D
EVP, R&D, Chief Medical Off.
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 38,675----(70%)
55.28K to 16.61K
05-Oct-17 8:11 PM
View: 
Butitta Cynthia M
Chief Operating Officer
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 93,667----(100%)
93.67K to 0
05-Oct-17 8:23 PM
View: 
Doumani Roy
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 1,807----(1%)
177.49K to 175.69K
05-Oct-17 8:28 PM
View: 
Peacock Jonathan M
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 1,807----(3%)
69.74K to 67.93K
05-Oct-17 8:21 PM
View: 
Ruchefsky Steven B
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 205,586----(100%)
205.59K to 0
05-Oct-17 8:28 PM
View: 
Peacock Jonathan M
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 67,932$180.00$12,227,800.00(100%)
67.93K to 0
05-Oct-17 8:16 PM
View: 
Tomasello Shawn
Chief Commercial Officer
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 39,933----(71%)
56.07K to 16.14K
05-Oct-17 8:24 PM
View: 
Humer Franz B
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 1,807----(28%)
6.43K to 4.62K
05-Oct-17 8:27 PM
View: 
Clark Ian T
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 1,776$180.00$319,680.00(100%)
1.78K to 0
05-Oct-17 8:23 PM
View: 
Doumani Roy
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition (change in control) 25,065$180.00$4,511,700.00(100%)
25.07K to 0
05-Oct-17 8:19 PM
View: 
Witte Owen N.
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 5,715----(9%)
64.25K to 58.53K
05-Oct-17 8:20 PM
View: 
Champsi Farah
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 1,807----(3%)
63.27K to 61.47K
05-Oct-17 8:25 PM
View: 
Kazam Joshoa A
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 70,050$180.00$12,609,000.00(94%)
74.41K to 4.36K
05-Oct-17 8:10 PM
View: 
Belldegrun Arie
Chairman, President and CEO
Director
Kite Pharma, Inc. (KITE) 03-Oct-17Disposition 159,160----(5%)
3.36M to 3.2M
05-Oct-17 8:20 PM
View: 
Champsi Farah
Director
Kite Pharma, Inc. (KITE) 29-Sep-17Gift 2,800----(4%)
66.07K to 63.27K
05-Oct-17 8:25 PM
View: 
Kazam Joshoa A
Director
Kite Pharma, Inc. (KITE) 28-Sep-17Acquisition (other) 70,050----1607%
4.36K to 74.41K
27-Sep-17 9:39 PM
View: 
Jenkinson Paul L
Chief Financial Officer
Kite Pharma, Inc. (KITE) 25-Sep-17Grant 2,500----23%
10.91K to 13.41K
27-Sep-17 9:41 PM
View: 
Wiezorek Jeffrey
SVP Clinical Development
Kite Pharma, Inc. (KITE) 25-Sep-17Market Sale 5,283$179.66$949,164.00(17%)
31.11K to 25.82K
(< 1%)
27-Sep-17 9:43 PM
View: 
Kim Helen Susan
EVP, Business Development
Kite Pharma, Inc. (KITE) 25-Sep-17Market Sale 3,171$179.66$569,714.00(13%)
24.86K to 21.69K
(< 1%)
05-Oct-17 8:16 PM
View: 
Tomasello Shawn
Chief Commercial Officer
Kite Pharma, Inc. (KITE) 25-Sep-17Gift 5,000----(8%)
61.07K to 56.07K
27-Sep-17 9:43 PM
View: 
Kim Helen Susan
EVP, Business Development
Kite Pharma, Inc. (KITE) 25-Sep-17Grant 6,000----32%
18.86K to 24.86K
27-Sep-17 9:38 PM
View: 
Belldegrun Arie
Chairman, President and CEO
Director
Kite Pharma, Inc. (KITE) 25-Sep-17Grant 50,000----2%
3.28M to 3.33M
27-Sep-17 9:42 PM
View: 
Moore Timothy L.
EVP, Technical Operations
Kite Pharma, Inc. (KITE) 25-Sep-17Grant 8,000----19%
41.89K to 49.89K
27-Sep-17 9:40 PM
View: 
Chang David D
EVP, R&D, Chief Medical Off.
Kite Pharma, Inc. (KITE) 25-Sep-17Grant 15,000----30%
50.35K to 65.35K
27-Sep-17 9:38 PM
View: 
Butitta Cynthia M
Chief Operating Officer
Kite Pharma, Inc. (KITE) 25-Sep-17Grant 8,000----7%
117.8K to 125.8K
27-Sep-17 9:44 PM
View: 
Tomasello Shawn
Chief Commercial Officer
Kite Pharma, Inc. (KITE) 25-Sep-17Grant 4,500----7%
60.77K to 65.27K
27-Sep-17 9:38 PM
View: 
Butitta Cynthia M
Chief Operating Officer
Kite Pharma, Inc. (KITE) 25-Sep-17Market Sale 4,228$179.66$759,619.00(3%)
125.8K to 121.57K
(< 1%)
05-Oct-17 8:10 PM
View: 
Belldegrun Arie
Chairman, President and CEO
Director
Kite Pharma, Inc. (KITE) 25-Sep-17Grant
Duplicate
50,000----2%
3.31M to 3.36M